$376.71 -14.59 (%) Regeneron Pharmaceuticals Inc - NASDAQ

Apr. 29, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Benzinga's Top Upgrades

    Benzinga | Feb. 16, 2016 | 08:57AM EST
  2. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big Change

    IBD | Feb. 9, 2016 | 12:41PM EST
  3. Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch

    IBD | Feb. 9, 2016 | 11:28AM EST
  4. Stock Futures Quietly Lower; Yamana Gold Continues Rally

    IBD | Feb. 9, 2016 | 08:55AM EST
  5. Why These Five Sector Leaders Became Former Leaders

    IBD | Feb. 8, 2016 | 16:30PM EST
  6. Benzinga's Top Downgrades

    Benzinga | Jan. 25, 2016 | 09:30AM EST
  7. SMR Rating Uncovers Stocks With Top Sales, Margins

    IBD | Jan. 20, 2016 | 16:50PM EST
  8. Medicines Company Spikes On Report Of Possible Sale

    IBD | Jan. 20, 2016 | 12:59PM EST
  9. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD | Jan. 15, 2016 | 15:00PM EST
  10. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD | Jan. 14, 2016 | 16:29PM EST
  11. Drug Stocks Mixed On Guidance Updates

    IBD | Jan. 12, 2016 | 18:45PM EST
  12. Horizon Up; Zoetis Trims EPS

    IBD | Jan. 12, 2016 | 18:40PM EST
  13. US Stock Futures Surge After Jobs Data

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  14. U.S. Stock Futures Surge After Jobs Data; El-Erian To Discuss Economic Situation

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  15. Regeneron, Sanofi Announce Sarilumab Biologics License Application Accepted for Review FDA

    Benzinga | Jan. 8, 2016 | 04:01AM EST
  16. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  17. Alphabet, Palo Alto Networks Lead Week's Insider Deals

    IBD | Dec. 31, 2015 | 13:59PM EST
  18. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  19. Big Biotech Amgen Facing Pivotal Year In 2016

    IBD | Dec. 17, 2015 | 17:08PM EST
  20. Regeneron, Sanofi Announce UnitedHealth Group to Provide Preferred Access Praluent Injection

    Benzinga | Dec. 11, 2015 | 04:13AM EST
  21. GoPro Downgraded, Ambarella PT Cut, Biotechs Are Buys

    IBD | Dec. 4, 2015 | 08:53AM EST
  22. LinkedIn, Palo Alto, Regeneron Profit Estimates Rising

    IBD | Dec. 4, 2015 | 08:02AM EST
  23. Stocks Close Lower; UnitedHealth Backs Its Forecasts

    IBD | Nov. 30, 2015 | 17:10PM EST
  24. Stocks Work Off Losses; Lululemon Further Weakens

    IBD | Nov. 30, 2015 | 15:04PM EST
  25. Stocks Trade Lower At Midday; Cambrex Hits New All-Time High

    IBD | Nov. 30, 2015 | 11:58AM EST
  26. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  27. Regeneron, Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent Injection Fully Enrolled

    Benzinga | Nov. 24, 2015 | 04:21AM EST
  28. CVS Makes Amgen New BFF

    IBD | Nov. 23, 2015 | 18:42PM EST
  29. CVS' Amgen Pick 'Raises The Bar' For Regeneron, Sanofi

    IBD | Nov. 23, 2015 | 16:06PM EST
  30. Weekly CFO Sells Highlights: Facebook, Fitbit, Regeneron Pharmaceuticals

    GuruFocus | Nov. 23, 2015 | 11:03AM EST
  31. Successful Bases Form Above The 50-Day Moving Average

    IBD | Nov. 17, 2015 | 17:50PM EST
  32. Stocks Strengthen In Afternoon; Biotechs Weak

    IBD | Nov. 16, 2015 | 13:27PM EST
  33. Vanguard Raises Stakes in Biogen, Mylan, Merck

    GuruFocus | Nov. 15, 2015 | 13:10PM EST
  34. Regeneron Tests Buy Point As New Drug Shows Promise

    IBD | Nov. 13, 2015 | 18:24PM EST
  35. Regeneron Recovers From Clinton Biotech Beat Down

    IBD | Nov. 12, 2015 | 11:27AM EST
  36. Gilead, Regeneron Stocks Weather Drug Pricing Furor

    IBD | Nov. 12, 2015 | 08:02AM EST
  37. Stock Futures Climb Toward Open; Facebook, LinkedIn, Alphabet Rise

    IBD | Nov. 11, 2015 | 08:52AM EST
  38. Regeneron, Sanofi Present Positive Results from Pivotal Phase 3 Study of Sarilumab at ACR Annual Meeting

    Benzinga | Nov. 8, 2015 | 08:29AM EST
  39. Regeneron, Allergan Beat Q3

    IBD | Nov. 4, 2015 | 18:42PM EST
  40. The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings

    GuruFocus | Nov. 4, 2015 | 15:42PM EST
  41. Regeneron Q3 Beats Views, But Praluent Launch Slow

    IBD | Nov. 4, 2015 | 15:41PM EST
  42. Stock Futures Gather Momentum; Baxalta, Tesla, Paycom Climb

    IBD | Nov. 4, 2015 | 09:17AM EST
  43. Facebook, Regeneron Lead Top Earnings To Watch Wed.

    IBD | Nov. 3, 2015 | 13:10PM EST
  44. Stocks Rally To Session Highs; Fitbit, Tesla Jump

    IBD | Nov. 2, 2015 | 14:38PM EST
  45. M&A News Fuels More Gains; Celgene, Regeneron Lead Nasdaq 100

    IBD | Nov. 2, 2015 | 13:19PM EST
  46. Facebook, Visa To Carry IBD 50 Earnings To Peak

    IBD | Oct. 31, 2015 | 08:02AM EST
  47. Regeneron Announces EU Approval of EYLEA® (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization

    Benzinga | Oct. 30, 2015 | 09:00AM EST
  48. Facebook Leads 5 L-T Growth Kings With Earnings On Tap

    IBD | Oct. 29, 2015 | 08:02AM EST
  49. Stocks Edge Up Ahead Of Fed; Akamai, Verisk Weigh On Nasdaq

    IBD | Oct. 28, 2015 | 10:46AM EST
  50. Stocks Fall Modestly; Fed Meeting Starts; IBM Hit By SEC Probe

    IBD | Oct. 27, 2015 | 14:44PM EST
Trading Center